Active06800217Private limited companyLoughton

TELETA PHARMA LIMITED

Significant control: Teleta Pharma Holdings Limited (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Teleta Pharma Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Teleta Pharma Limited sell?

Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

TELETA PHARMA LIMITED is an active private limited company (company number 06800217) incorporated on 23 January 2009, registered in Loughton. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest full accounts cover the period ending 30 June 2025, showing net assets of £4.62m and cash of £476k, with 39 employees on average. Turnover was £13.34m and profit for the year £730k. Net assets rose 19% on the prior period (£3.89m).

Peer position · net assets

By net assets it sits in the top quarter of 319 comparable companies in Greater London (median £6,251, upper quartile £199k).

02

Ownership and control

1 active · 2 other
  • Teleta Pharma Holdings Limited
    corporate entity, United Kingdom · since 22 May 2019
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • Mr Joel Rabin
    Individual · since 6 April 2016 · ceased 21 May 2019
    • owns 25–50% of shares
    • holds 25–50% of voting rights
  • Mr Barry Christian
    Individual · since 6 April 2016 · ceased 22 May 2019
    • owns 25–50% of shares
    • holds 25–50% of voting rights

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
23 January 200917 yrs ago
Next accounts due
30 March 2027in 157 days
Confirmation statement due
6 February 2027in 105 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 46460
Wholesale of pharmaceutical goods
Accounts type
Full
Size band
SmallCompanies Act thresholds
05

Financials

3 periods on record · latest ending 30 June 2025
Net assets
£4.62m
+19%vs Jun 2024
Cash at bank
£476k
−26%vs Jun 2024
Turnover
£13.34m
−5%vs Jun 2024
Employees
39
−2%vs Jun 2024
Net assets
£4.62m
Cash at bank
£476k
Turnover
£13.34m
Profit for the year
£730k
Average employees
39
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
30 June 2025£4.62m£476k—£5.07m£13.34m£730k39
30 June 2024£3.89m£641k—£6.03m£14.00m£638k40
1 July 2023———————
Current ratio1.88Current assets ÷ creditors within one year
Net margin5.5%Profit for the year ÷ turnover
Cash per employee£12kCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £4,619,672 at 30 June 2025
  • Net assets up 10% or more on the prior period+18.8% vs prior period
  • Current assets at least 1.5× creditors within one yearCurrent ratio 1.88
  • Cash at bank of £50,000 or moreCash £476,253
  • Three or more accounting periods on record3 periods on record
  • Incorporated five or more years agoIncorporated 23 January 2009

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Next accounts duein 157 days
  2. Confirmation statement duein 105 days
  3. Accounts period endNet assets £4.62m · full accounts
  4. Accounts period endNet assets £3.89m · full accounts
  5. Accounts period end
  6. Incorporated
08

Similar companies in Greater London

Same activity (wholesale of pharmaceutical goods), closest in incorporation date
09

Reminders for TELETA PHARMA LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.